COVID-19患者中全球糖尿病患病率及其对COVID-19相关重症和死亡的贡献:系统综述与Meta分析
该系统综述与Meta分析纳入729项研究、29874938例COVID-19患者,计算各疾病阶段糖尿病患病率及糖尿病对重症和死亡的人群归因分数。确诊、住院、重症和死亡病例的糖尿病合并患病率分别为14.7%、21.4%、28.9%和34.6%,糖尿病对重症和死亡的PAF分别为9.5%和16.8%。
要点
- 确诊COVID-19病例的糖尿病合并患病率为14.7%(95%CI 12.5-16.9)。
- 糖尿病对COVID-19重症和死亡的PAF分别为9.5%和16.8%。
- 高收入、高医疗可及性与质量指数及低糖尿病疾病负担国家的PAF较低。
核心结论
- 糖尿病患病率随COVID-19疾病严重程度增加而升高,糖尿病占重症COVID-19病例的9.5%和死亡的16.8%,且因国家收入、医疗可及性与质量指数及糖尿病疾病负担而异。
研究设计与样本
- 系统综述与Meta分析,纳入729项研究、共29874938例COVID-19患者,提取研究信息、COVID-19疾病阶段和糖尿病患病率。
主要发现
- 确诊COVID-19病例的糖尿病合并患病率为14.7%(95%CI 12.5-16.9)。
- 非住院病例的糖尿病合并患病率为10.4%(95%CI 7.6-13.6),住院病例为21.4%(95%CI 20.4-22.5)。
- 非重症病例的糖尿病合并患病率为11.9%(95%CI 10.2-13.7),重症病例为28.9%(95%CI 27.0-30.8)。
- 死亡个体的糖尿病合并患病率为34.6%(95%CI 32.8-36.5)。
- 多变量Meta回归分析解释了合并患病率异质性的53-83%;基于改良比较风险评估模型估计,糖尿病对COVID-19感染者发生重症的总体PAF为9.5%(95%CI 7.3-11.7),对COVID-19相关死亡的PAF为16.8%(95%CI 14.8-18.8)。
局限性
- 大多数研究存在高偏倚风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: COVID-19 and diabetes both contribute to large global disease burdens. PURPOSE: To quantify the prevalence of diabetes in various COVID-19 disease stages and calculate the population attributable fraction (PAF) of diabetes to COVID-19-related severity and mortality. DATA SOURCES: Systematic review identified 729 studies with 29,874,938 COVID-19 patients. STUDY SELECTION: Studies detailed the prevalence of diabetes in subjects with known COVID-19 diagnosis and severity. DATA EXTRACTION: Study information, COVID-19 disease stages, and diabetes prevalence were extracted. DATA SYNTHESIS: The pooled prevalence of diabetes in stratified COVID-19 groups was 14.7% (95% CI 12.5-16.9) among confirmed cases, 10.4% (7.6-13.6) among nonhospitalized cases, 21.4% (20.4-22.5) among hospitalized cases, 11.9% (10.2-13.7) among nonsevere cases, 28.9% (27.0-30.8) among severe cases, and 34.6% (32.8-36.5) among deceased individuals, respectively. Multivariate metaregression analysis explained 53-83% heterogeneity of the pooled prevalence. Based on a modified version of the comparative risk assessment model, we estimated that the overall PAF of diabetes was 9.5% (7.3-11.7) for the presence of severe disease in COVID-19-infected individuals and 16.8% (14.8-18.8) for COVID-19-related deaths. Subgroup analyses demonstrated that countries with high income levels, high health care access and quality index, and low diabetes disease burden had lower PAF of diabetes contributing to COVID-19 severity and death. LIMITATIONS: Most studies had a high risk of bias. CONCLUSIONS: The prevalence of diabetes increases with COVID-19 severity, and diabetes accounts for 9.5% of severe COVID-19 cases and 16.8% of deaths, with disparities according to country income, health care access and quality index, and diabetes disease burden.
引用
- Li R, Shen M, Yang Q, et al. Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19- Related Severity and Mortality: A Systematic Review and Meta-analysis. Diabetes Care. 2023. PMID: 36826982. doi:10.2337/dc22-1943
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。